Literature DB >> 16965284

Immune modulation by helminthic infections: worms and viral infections.

S M Kamal1, K El Sayed Khalifa.   

Abstract

Helminthic infections occur worldwide, especially in developing countries. About one-quarter of the world's population, 1.5 billion, are infected with one or more of the major soil-transmitted helminths, including hookworms, ascarids, and whipworms. Schistosomes infect more than 200 million people worldwide with 600 million at risk in 74 countries. The interaction between helminths and the host's immune system provokes particular immunomodulatory and immunoregulatory mechanisms that ensure their survival in the host for years. However, these changes might impair the immunological response to bystander bacterial, viral, and protozoal pathogens and to vaccination. Modulation of the immune system by infection with helminthic parasites is proposed to reduce the levels of allergic responses and to protect against inflammatory bowel disease. In this review, we summarize the immunological milieu associated with helminthic infections and its impact on viral infections, mainly hepatitis B virus, hepatitis C virus, and human immunodeficiency virus in humans and experimental animals.

Entities:  

Mesh:

Year:  2006        PMID: 16965284     DOI: 10.1111/j.1365-3024.2006.00909.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  32 in total

1.  T cell-, interleukin-12-, and gamma interferon-driven viral clearance in measles virus-infected brain tissue.

Authors:  Samantha R Stubblefield Park; Mi Widness; Alan D Levine; Catherine E Patterson
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

Review 2.  The impact of successive infections on the lung microenvironment.

Authors:  Arnaud Didierlaurent; John Goulding; Tracy Hussell
Journal:  Immunology       Date:  2007-12       Impact factor: 7.397

Review 3.  Decomposing health: tolerance and resistance to parasites in animals.

Authors:  Lars Råberg; Andrea L Graham; Andrew F Read
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-01-12       Impact factor: 6.237

4.  Does HIV/AIDS have a biological impact on the risk of human papillomavirus-related cancers?

Authors:  Howard D Strickler
Journal:  J Natl Cancer Inst       Date:  2009-07-31       Impact factor: 13.506

Review 5.  Schistosomiasis-associated pulmonary hypertension: pulmonary vascular disease: the global perspective.

Authors:  Brian B Graham; Angela Pontes Bandeira; Nicholas W Morrell; Ghazwan Butrous; Rubin M Tuder
Journal:  Chest       Date:  2010-06       Impact factor: 9.410

6.  Quantitative analysis of Northern bobwhite (Colinus virginianus) cytokines and TLR expression to eyeworm (Oxyspirura petrowi) and caecal worm (Aulonocephalus pennula) glycoproteins.

Authors:  Aravindan Kalyanasundaram; Kendall R Blanchard; Brett J Henry; Cassandra Henry; Matthew Z Brym; Ronald J Kendall
Journal:  Parasitol Res       Date:  2019-08-15       Impact factor: 2.289

7.  [Chronic hepatitis B with an unexpected coinfection].

Authors:  Thomas Göbel; Andreas Erhardt; Joachim Richter; Christopher Poremba; Dieter Häussinger
Journal:  Med Klin (Munich)       Date:  2010-12-07

8.  Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trial.

Authors:  Judd L Walson; Phelgona A Otieno; Margaret Mbuchi; Barbra A Richardson; Barbara Lohman-Payne; Steve Wanyee Macharia; Julie Overbaugh; James Berkley; Eduard J Sanders; Michael H Chung; Grace C John-Stewart
Journal:  AIDS       Date:  2008-08-20       Impact factor: 4.177

Review 9.  Regulation of type 1 diabetes, tuberculosis, and asthma by parasites.

Authors:  Zhugong Liu; Qian Liu; David Bleich; Padmini Salgame; William C Gause
Journal:  J Mol Med (Berl)       Date:  2009-10-21       Impact factor: 4.599

10.  Landscape features and helminth co-infection shape bank vole immunoheterogeneity, with consequences for Puumala virus epidemiology.

Authors:  E Guivier; M Galan; H Henttonen; J-F Cosson; N Charbonnel
Journal:  Heredity (Edinb)       Date:  2013-10-23       Impact factor: 3.821

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.